Cardiovascular Systems Inc Contracts & Agreements
256 Contracts & Agreements
- Business Finance (46 contracts)
- Business Operations (13)
- Human Resources (107)
- Intellectual Property (4)
- Mergers & Acquisitions (2)
- Real Estate (10)
- Uncategorized (74)
- Loan Agreement, dated as of December 30, 2022, by and between the Company and Chansu Vascular Technologies, LLC (Filed With SEC on February 9, 2023)
- First Amended and Restated Acquisition Option Agreement, dated as of December 30, 2022, by and among the Company, Chansu Vascular Technologies, LLC, and the members of Chansu... (Filed With SEC on February 9, 2023)
- Product Development Agreement, dated as of January 2 (Filed With SEC on February 9, 2023)
- Agreement and Plan of Merger, dated as of February 8, 2023, by and among the Company, Abbott Laboratories, and Cobra Acquisition Co (Filed With SEC on February 9, 2023)
- Fiscal 2023 Executive Officer Bonus Plan and Equity Compensation (Filed With SEC on August 18, 2022)
- Fiscal 2023 Director Compensation Arrangements (Filed With SEC on August 18, 2022)
- Separation Agreement, dated June 6, 2022, by and between the Company and Rhonda Robb (Filed With SEC on August 18, 2022)
- Separation Agreement, dated June 30, 2022, by and between the Company and David Whitescarver (Filed With SEC on August 18, 2022)
- Consulting Agreement, dated July 1, 2022, by and between the Company and David Whitescarver (Filed With SEC on August 18, 2022)
- Form of Performance-Vest Restricted Stock Award Agreement (Revenue Growth) under Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on August 18, 2022)
- Form of Performance-Vest Restricted Stock Award Agreement (Total Stockholder Return) under Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on August 18, 2022)
- Transition Agreement, dated December 16, 2021, by and between the Company and David Whitescarver (Filed With SEC on February 3, 2022)
- Fiscal 2022 Executive Officer Bonus Plan and Equity Compensation (Filed With SEC on August 19, 2021)
- Fiscal 2022 Director Compensation Arrangements (Filed With SEC on August 19, 2021)
- Fourth Amendment to Build-to-Suit Lease, between Pearland Economic Development Corporation and Cardiovascular Systems, Inc. dated December 18, 2020 (Filed With SEC on February 4, 2021)
- Supply Agreement, between Cardiovascular Systems, Inc. and Fresenius Kabi AB, effective April 4, 2011 (Filed With SEC on November 5, 2020)
- Amendment No. 1 to Product Schedule, between Cardiovascular Systems, Inc. and Fresenius Kabi AB, effective March 27, 2016 (Filed With SEC on November 5, 2020)
- Amendment to Purchasing Agreement, effective October 1, 2020, between Cardiovascular Systems, Inc. and Healthtrust Purchasing Group, L.P (Filed With SEC on November 5, 2020)
- Fiscal 2021 Executive Officer Bonus Plan and Equity Compensation (Filed With SEC on August 20, 2020)
- Fiscal 2021 Director Compensation Arrangements (Filed With SEC on August 20, 2020)
- Supply Agreement, between Cardiovascular Systems, Inc. and Abrasive Technology, Inc, effective June 19, 2020 (Filed With SEC on August 20, 2020)
- Underwriting Agreement, dated June 9, 2020 (Filed With SEC on June 12, 2020)
- Amendment No. 2 to Product Schedule, between Cardiovascular Systems, Inc. and Fresenius Kabi AB, effective March 18, 2020 (Filed With SEC on May 7, 2020)
- Form of Board Restricted Stock Award Agreement (in lieu of cash retainer) under Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
- Form of Board RSU Agreement (annual) under Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
- Form of Board RSU Agreement (in lieu of cash retainer) under Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
- Form of Performance-Vest Restricted Stock Award Agreement under Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
- Form of Time-Vest Restricted Stock Award Agreement under Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
- Form of Stock Option Agreement under Amended and Restated 2017 Equity Incentive Form (Filed With SEC on May 7, 2020)
- First Amendment to Loan and Security Agreement, by and between Cardiovascular Systems, Inc. and Silicon Valley Bank, dated March 26, 2020 (Filed With SEC on May 7, 2020)
- Amendment No. 2 to Supply Agreement, between Cardiovascular Systems, Inc. and Fresenius Kabi AB, effective March 18, 2020 (Filed With SEC on May 7, 2020)
- Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
- Separation Agreement, dated August 30, 2019, by and between the Company and Laura J. Gillund (Filed With SEC on October 31, 2019)
- Consulting Agreement dated August 31, 2019, by and between the Company and Laura J. Gillund (Filed With SEC on October 31, 2019)
- Description of Capital Stock (Filed With SEC on August 23, 2019)
- Fiscal 2020 Executive Officer Bonus Plan and Equity Compensation (Filed With SEC on August 23, 2019)
- Fiscal Year 2020 Director Compensation Arrangements (Filed With SEC on August 23, 2019)
- Transition Agreement, dated January 9, 2019, by and between the Company and Laura J. Gillund (Filed With SEC on May 3, 2019)
- Separation Agreement, dated August 15, 2018, by and between the Company and Laurence L. Betterley (Filed With SEC on November 2, 2018)
- Consulting Agreement, dated August 16, 2018, by and between the Company and Laurence L. Betterley (Filed With SEC on November 2, 2018)
- Third Amendment of Lease, between Pearland Economic Development Corporation and Cardiovascular Systems, Inc., dated August 30, 2018 (Filed With SEC on November 2, 2018)
- Fiscal Year 2019 Executive Officer Base Salaries (Filed With SEC on August 23, 2018)
- Fiscal 2019 Executive Officer Bonus Plan and Equity Compensation (Filed With SEC on August 23, 2018)
- Fiscal Year 2019 Director Compensation Arrangements (Filed With SEC on August 23, 2018)
- Cardiovascular Systems, Inc. Executive Officer Severance Plan (restated August 22, 2018) (Filed With SEC on August 23, 2018)
- Second Amendment of Lease, between Pearland Economic Development Corporation and Cardiovascular Systems, Inc., dated April 9, 2018 (Filed With SEC on August 23, 2018)
- Separation Agreement, dated January 31, 2018, by and between the Company and Kevin Kenny (Filed With SEC on May 4, 2018)
- Offer Letter and Employment Agreement, dated January 12, 2018, by and between the Company and Rhonda Robb (Filed With SEC on May 4, 2018)
- Offer Letter and Employment Agreement, dated February 7, 2018, by and between the Company and Jeff Points (Filed With SEC on May 4, 2018)
- Transition Letter, dated February 6, 2018, by and between the Company and Larry Betterley (Filed With SEC on May 4, 2018)
- Purchasing Agreement, effective May 1, 2018, between Cardiovascular Systems, Inc. and Healthtrust Purchasing Group, L.P (Filed With SEC on May 4, 2018)
- First Amendment of Lease, between Pearland Economic Development Corporation and Cardiovascular Systems, Inc., dated November 10, 2017 (Filed With SEC on February 9, 2018)
- Amendment to Purchasing Agreement between Cardiovascular Systems, Inc. and Healthtrust Purchasing Group, L.P (Filed With SEC on February 9, 2018)
- Cardiovascular Systems, Inc. 2017 Equity Incentive Plan (Filed With SEC on November 17, 2017)
- Form of Board Restricted Stock Award Agreement (in lieu of cash retainer) under 2017 Equity Incentive Plan (Filed With SEC on November 17, 2017)
- Form of Board RSU Agreement (annual) under 2017 Equity Incentive Plan (Filed With SEC on November 17, 2017)
- Form of Board RSU Agreement (in lieu of cash retainer) under 2017 Equity Incentive Plan (Filed With SEC on November 17, 2017)
- Form of Performance Unit Agreement (cash settled) under 2017 Equity Incentive Plan (Filed With SEC on November 17, 2017)
- Form of Performance-Vest Restricted Stock Award Agreement under 2017 Equity Incentive Plan (Filed With SEC on November 17, 2017)
- Form of Time-Vest Restricted Stock Award Agreement under 2017 Equity Incentive Plan (Filed With SEC on November 17, 2017)
- Executive Officer Severance Plan (restated November 15, 2017) (Filed With SEC on November 17, 2017)
- FISCAL YEAR 2018 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on August 24, 2017)
- FISCAL 2018 EXECUTIVE OFFICER BONUS PLAN AND EQUITY COMPENSATION (Filed With SEC on August 24, 2017)
- FISCAL 2018 DIRECTOR COMPENSATION ARRANGEMENTS (Filed With SEC on August 24, 2017)
- PERFORMANCE UNIT AWARD (CASH SETTLED) CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on August 24, 2017)
- Amendment to Purchasing Agreement Agreement No. 4037 Vendor: Cardiovascular Systems, Inc Agreement Date: August 1, 2014 Amendment Date: December 1, 2017 (Filed With SEC on August 24, 2017)
- ACKNOWLEDGMENT AND SIGNATURE (Filed With SEC on August 24, 2017)
- SECOND AMENDMENT TO PURCHASE AND SALE AGREEMENT (Filed With SEC on May 5, 2017)
- THIRD AMENDMENT TO PURCHASE AND SALE AGREEMENT (Filed With SEC on May 5, 2017)
- FOURTH AMENDMENT TO PURCHASE AND SALE AGREEMENT (Filed With SEC on May 5, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on May 5, 2017)
- LEASE AGREEMENT (Filed With SEC on May 5, 2017)
- PURCHASE AND SALE AGREEMENT (Filed With SEC on February 3, 2017)
- FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT (Filed With SEC on February 3, 2017)
- Amendment to Purchasing Agreement Agreement No. 4037 Vendor: Cardiovascular Systems Inc Agreement Date: August 1, 2014 Amendment Date: August 1, 2017 (Filed With SEC on February 3, 2017)
- FISCAL YEAR 2017 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on August 25, 2016)
- FISCAL 2017 EXECUTIVE OFFICER BONUS PLAN AND EQUITY COMPENSATION (Filed With SEC on August 25, 2016)
- FISCAL 2017 DIRECTOR COMPENSATION ARRANGEMENTS (Filed With SEC on August 25, 2016)
- CARDIOVASCULAR SYSTEMS, INC. EXECUTIVE OFFICER SEVERANCE PLAN Restatement Date: July 26, 2016 (Filed With SEC on August 25, 2016)
- ACKNOWLEDGMENT AND SIGNATURE (Filed With SEC on August 25, 2016)
- PERFORMANCE UNIT AWARD (CASH SETTLED) CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on August 25, 2016)
- RESTRICTED STOCK AGREEMENT PERFORMANCE-BASED VESTING CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on August 25, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 25, 2016)
- SETTLEMENT AGREEMENT (Filed With SEC on June 28, 2016)
- CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND CARDIOVASCULAR SYSTEMS, INC. (Filed With SEC on June 28, 2016)
- AMENDMENT NO. 1 TO SUPPLY AGREEMENT (Filed With SEC on May 6, 2016)
- AMENDMENT NO. 1 TO PRODUCT SCHEDULE (Filed With SEC on May 6, 2016)
- ACKNOWLEDGMENT AND SIGNATURE (Filed With SEC on February 29, 2016)
- /s/ Scott R. WardDate: November 30, 2015 (Filed With SEC on February 2, 2016)
- CONFIDENTIALITY AND ASSIGNMENT OF INVENTIONS AGREEMENT (Filed With SEC on February 2, 2016)
- CARDIOVASCULAR SYSTEMS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on November 19, 2015)
- FISCAL YEAR 2016 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on August 27, 2015)
- FISCAL 2016 EXECUTIVE OFFICER BONUS PLAN AND EQUITY COMPENSATION (Filed With SEC on August 27, 2015)
- FISCAL 2016 DIRECTOR COMPENSATION ARRANGEMENTS (Filed With SEC on August 27, 2015)
- CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN Amended as of May 19, 2015 SECTION 1. DEFINITIONS (Filed With SEC on August 27, 2015)
- AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2015)
- CARDIOVASCULAR SYSTEMS, INC. EXECUTIVE OFFICER SEVERANCE PLAN Restatement Date: February 27, 2015 (Filed With SEC on May 8, 2015)
- RESTRICTED STOCK UNIT AGREEMENT CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on May 8, 2015)
- RESTRICTED STOCK AGREEMENT CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on May 8, 2015)
- RESTRICTED STOCK AGREEMENT TIME-BASED VESTING CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on February 6, 2015)
- RESTRICTED STOCK AGREEMENT PERFORMANCE BASED VESTING CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on February 6, 2015)
- CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN SECTION 1. DEFINITIONS (Filed With SEC on November 14, 2014)
- RESTRICTED STOCK AGREEMENT TIME-BASED VESTING CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on November 14, 2014)
- RESTRICTED STOCK AGREEMENT PERFORMANCE BASED VESTING CARDIOVASCULAR SYSTEMS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on November 14, 2014)
- FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 7, 2014)
- ACKNOWLEDGMENT AND SIGNATURE (Filed With SEC on November 7, 2014)
- FISCAL YEAR 2015 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on August 28, 2014)
- FISCAL 2015 EXECUTIVE OFFICER BONUS PLAN AND EQUITY COMPENSATION (Filed With SEC on August 28, 2014)
- FISCAL 2015 DIRECTOR COMPENSATION ARRANGEMENTS (Filed With SEC on August 28, 2014)
- PURCHASING AGREEMENT Products (Filed With SEC on August 28, 2014)
- Fourth Amendment to Loan And Security Agreement (Filed With SEC on August 28, 2014)
- DEVELOPMENT SERVICES AGREEMENT (Filed With SEC on August 28, 2014)
- CONTRACT FOR PRIVATE REDEVELOPMENT By and Among THE CITY OF NEW BRIGHTON And RYAN COMPANIES US, INC. And CARDIOVASCULAR SYSTEMS, INC. (CARDIOVASCULAR SYSTEMS PROJECT) TABLE OF... (Filed With SEC on August 28, 2014)
- DESIGN-BUILD (Filed With SEC on August 28, 2014)
- CARDIOVASCULAR SYSTEMS, INC. DEFERRED COMPENSATION PLAN (Filed With SEC on December 17, 2013)
- CARDIOVASCULAR SYSTEMS, INC. (aDelaware corporation) 2,608,696 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 21, 2013)
- FISCAL YEAR 2014 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on September 11, 2013)
- FISCAL 2014 DIRECTOR COMPENSATION ARRANGEMENTS (Filed With SEC on September 11, 2013)
- Fiscal 2014 Executive Officer Bonus Plan (Filed With SEC on September 11, 2013)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on September 11, 2013)
- MODIFICATION NO. 4 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on September 11, 2013)
- 2,000,000 Shares CARDIOVASCULAR SYSTEMS, INC. Common Stock, Par Value $0.001 Per Share UNDERWRITING AGREEMENT (Filed With SEC on March 20, 2013)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on February 8, 2013)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on February 8, 2013)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on February 8, 2013)
- AMENDMENT NO. 1 TO CARDIOVASCULAR SYSTEMS, INC. EXECUTIVE OFFICER SEVERANCE PLAN (Filed With SEC on February 8, 2013)
- FISCAL YEAR 2013 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on September 10, 2012)
- FISCAL 2013 DIRECTOR COMPENSATION ARRANGEMENTS (Filed With SEC on September 10, 2012)
- Fiscal 2013 Executive Officer Bonus Plan (Filed With SEC on September 10, 2012)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on September 10, 2012)
- MODIFICATION NO. 3 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on September 10, 2012)
- AMENDMENT TO CORPORATE JOB CREATION AGREEMENT (Filed With SEC on September 10, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on September 10, 2012)
- 1,780,000 Shares CARDIOVASCULAR SYSTEMS, INC. Common Stock, Par Value $0.001 Per Share UNDERWRITING AGREEMENT (Filed With SEC on May 22, 2012)
- FOURTH AMENDMENT TO LEASE (Filed With SEC on May 8, 2012)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 9, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on February 9, 2012)
- WARRANT (Filed With SEC on February 9, 2012)
- MODIFICATION NO. 2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 9, 2012)
- WARRANT (Filed With SEC on February 9, 2012)
- WARRANT (Filed With SEC on February 9, 2012)
- SUMMARY OF FISCAL 2012 EXECUTIVE OFFICER BONUS PLAN (Filed With SEC on February 9, 2012)
- Amendment to Purchasing Agreement Agreement No. 4037 Vendor: Cardiovascular Systems Inc Effective Date: July 15, 2011 Amendment Date: November 1, 2011 (Filed With SEC on November 8, 2011)
- MODIFICATION NO. 1 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 8, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 12, 2011)
- CARDIOVASCULAR SYSTEMS, INC. SUMMARY OF FISCAL YEAR 2012 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on September 12, 2011)
- DIRECTOR COMPENSATION ARRANGEMENTS (Filed With SEC on September 12, 2011)
- PURCHASING AGREEMENT Products (Filed With SEC on September 12, 2011)
- RESTRICTED STOCK AGREEMENT CARDIOVASCULAR SYSTEMS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN (Filed With SEC on September 12, 2011)
- RESTRICTED STOCK UNIT AGREEMENT CARDIOVASCULAR SYSTEMS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN (Filed With SEC on September 12, 2011)
- CARDIOVASCULAR SYSTEMS, INC. EXECUTIVE OFFICER SEVERANCE PLAN Effective Date: June 28, 2010 (Filed With SEC on September 12, 2011)
- Current assets (Filed With SEC on May 13, 2011)
- SUMMARY OF FISCAL YEAR 2011 EXECUTIVE OFFICER ANNUAL CASH INCENTIVE COMPENSATION PLAN (Filed With SEC on November 12, 2010)
- SETTLEMENT AGREEMENT (Filed With SEC on November 12, 2010)
- Differential Sanding Reduces Risk of Adverse Events. The Diamondback Systems are designed to differentiate between hard plaque and soft compliant arterial tissue. Arteries are... (Filed With SEC on September 28, 2010)
- Differential Sanding Reduces Risk of Adverse Events. The Diamondback Systems are designed to differentiate between hard plaque and soft compliant arterial tissue. Arteries are... (Filed With SEC on September 28, 2010)
- Differential Sanding Reduces Risk of Adverse Events. The Diamondback Systems are designed to differentiate between hard plaque and soft compliant arterial tissue. Arteries are... (Filed With SEC on September 28, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- Current assets (Filed With SEC on May 14, 2010)
- ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Filed With SEC on November 16, 2009)
- Differential Sanding Reduces Risk of Adverse Events. The Diamondback 360 is designed to differentiate between plaque and compliant arterial tissue. The diamond grit coated offset... (Filed With SEC on September 29, 2009)
- Differential Sanding Reduces Risk of Adverse Events. The Diamondback 360 is designed to differentiate between plaque and compliant arterial tissue. The diamond grit coated offset... (Filed With SEC on September 29, 2009)
- Differential Sanding Reduces Risk of Adverse Events. The Diamondback 360 is designed to differentiate between plaque and compliant arterial tissue. The diamond grit coated offset... (Filed With SEC on September 29, 2009)
- Differential Sanding Reduces Risk of Adverse Events. The Diamondback 360 is designed to differentiate between plaque and compliant arterial tissue. The diamond grit coated offset... (Filed With SEC on September 29, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- Current assets (Filed With SEC on May 14, 2009)
- CARDIOVASCULAR SYSTEMS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 18, 2009)
- TERMINATION OF FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on March 18, 2009)
- Entry Into Material Definitive Agreement (Filed With SEC on March 3, 2009)
- Entry Into Material Definitive Agreement (Filed With SEC on March 3, 2009)
- Current assets (Filed With SEC on February 13, 2009)
- Current assets (Filed With SEC on February 13, 2009)
- AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (Filed With SEC on November 4, 2008)
- CARDIOVASCULAR SYSTEMS, INC. SUMMARY OF CALENDAR 2008 EXECUTIVE OFFICER BASE SALARIES (Filed With SEC on September 8, 2008)
- Name of Borrower Cardiovascular Systems, Inc. By: /s/ Laurence L. Betterley Title: CFO (Signature of Authorized Signatory of Borrower)* (Title of Authorized Signatory of Borrower)... (Filed With SEC on September 8, 2008)
- Form of Underwriting Agreement (Filed With SEC on August 15, 2008)
- Certificate Specimen (Filed With SEC on August 15, 2008)
- Summary of Calendar 2008 Executive Officer Annual Cash Incentive Compensation (Filed With SEC on August 15, 2008)
- Separation Agreement- Peter Letendre (Filed With SEC on August 5, 2008)
- Consulting Agreement- Peter Letendre (Filed With SEC on August 5, 2008)
- Seperation Agreement- Roger Echols (Filed With SEC on August 5, 2008)
- Consulting Agreement- Roger Echols (Filed With SEC on August 5, 2008)
- Client's Agreement (Filed With SEC on May 23, 2008)
- Summary of Calendar 2008 Executive Officer Annual Cash Incentive Compensation (Filed With SEC on May 9, 2008)
- Summary of Calendar 2008 Executive Officer Annual Cash Incentive Compensation (Filed With SEC on April 18, 2008)
- Client's Agreement - UBS Financial Services, Inc (Filed With SEC on April 18, 2008)
- Employment Agreement - Laurence L. Betterley (Filed With SEC on April 18, 2008)
- /s/ Kenneth Collins Kenneth Collins, Chief Executive Officer (Filed With SEC on April 1, 2008)
- /s/ Kenneth Collins Kenneth Collins, Chief Executive Officer (Filed With SEC on April 1, 2008)
- Summary of Calendar 2008 Executive Officer Base Salaries (Filed With SEC on March 20, 2008)
- Summary of Calendar 2008 Executive Officer Annual Cash Incentive Compensation (Filed With SEC on March 20, 2008)
- Investor's Rights Agreement (Filed With SEC on January 22, 2008)
- Amendment No. 1 to Investor's Rights Agreement (Filed With SEC on January 22, 2008)
- Amendment No. 2 to Investor's Rights Agreement (Filed With SEC on January 22, 2008)
- Amendment No. 3 to Investor's Rights Agreement (Filed With SEC on January 22, 2008)
- 2007 Equity Incentive Plan (Filed With SEC on January 22, 2008)
- Form of Incentive Stock Option Agreement (Filed With SEC on January 22, 2008)
- Form of Non-Qualified Stock Option Agreement (Filed With SEC on January 22, 2008)
- Form of Restricted Stock Agreement (Filed With SEC on January 22, 2008)
- Form of Restricted Stock Unit Agreement (Filed With SEC on January 22, 2008)
- Form of Performance Share Award (Filed With SEC on January 22, 2008)
- Form of Performance Unit Award (Filed With SEC on January 22, 2008)
- Form of Stock Appreciation Rights Agreement (Filed With SEC on January 22, 2008)
- 2003 Stock Option Plan (Filed With SEC on January 22, 2008)
- Form of Incentive Stock Option Agreement (Filed With SEC on January 22, 2008)
- Form of Non-Qualified Stock Option Agreement (Filed With SEC on January 22, 2008)
- 1991 Stock Option Plan (Filed With SEC on January 22, 2008)
- Form of Non-Qualified Stock Option Agreement (Filed With SEC on January 22, 2008)
- Employment Agreeement (Filed With SEC on January 22, 2008)
- Amended and Restated Employment Agreement (Filed With SEC on January 22, 2008)
- Amendment to Employment Agreement (Filed With SEC on January 22, 2008)
- Form of Standard Employment Agreement (Filed With SEC on January 22, 2008)
- Lease, Dated September 26, 2005 (Filed With SEC on January 22, 2008)
- First Amendment to the Lease (Filed With SEC on January 22, 2008)
- Second Amendment to the Lease (Filed With SEC on January 22, 2008)
- Third Amendment to the Lease (Filed With SEC on January 22, 2008)
- Amendment to Employment Agreement - Kenneth J. Collins (Filed With SEC on June 19, 2007)
- Amendment to Employment Agreement - Roger Echols, M.D (Filed With SEC on June 19, 2007)
- Amendment to Employment Agreement - Mark Smith (Filed With SEC on June 19, 2007)
- Amendment to Employment Agreement - Nebojsa Janjic, Ph.D (Filed With SEC on June 19, 2007)
- Amendment to Employment Agreement - Peter Letendre, Pharm.D (Filed With SEC on June 19, 2007)
- Replidyne, Inc. Variable Incentive Bonus Plan Effective Calendar Year 2007 (Filed With SEC on March 9, 2007)
- Form of Underwriting Agreement (Filed With SEC on June 26, 2006)
- Specimen Common Stock Certificate (Filed With SEC on June 26, 2006)
- 2006 Equity Incentive Plan (Filed With SEC on June 26, 2006)
- 2006 Employee Stock Purchase Plan (Filed With SEC on June 26, 2006)
- Summary of Director Compensation Program (Filed With SEC on June 26, 2006)
- License Agreement (Filed With SEC on June 26, 2006)
- Amendment to License Agreement (Filed With SEC on June 26, 2006)
- Second Amendment to License Agreement (Filed With SEC on June 26, 2006)
- Supply Agreement (Filed With SEC on June 26, 2006)
- Collaboration and Commercialization Agreement (Filed With SEC on June 26, 2006)
- 2006 Equity Incentive Plan (Filed With SEC on June 13, 2006)
- 2006 Employee Stock Purchase Plan (Filed With SEC on June 13, 2006)
- Third Amendment to License Agreement (Filed With SEC on May 22, 2006)